Patients with atopic dermatitis (AD) report a desire for climate-health education, which is infrequently addressed by ...

Lawrence Eichenfield, MD, outlines a patient-centered approach to atopic dermatitis, assessing disease history, life impact, and prior therapy use.

EXTON, PA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible ...

Atopic dermatitis involves complex immune and neuronal pathways, with biologics targeting IL-4, IL-13, and IL-31 showing promise in treatment. Diagnostic and treatment strategies must consider skin ...

Among patients with moderate to severe atopic dermatitis, atopic comorbidities did not change the benefits seen with lebrikizumab, according to data published in Annals of Allergy, Asthma & Immunology ...

Please provide your email address to receive an email when new articles are posted on . 32.8% of rocatinlimab-treated patients achieved the co-primary endpoint of EASI 75 by week 24. 19.3% reached the ...

Topline data were announced from two phase 3 trials evaluating amlitelimab for the treatment of moderate to severe atopic dermatitis.

How do dermatologists diagnose atopic dermatitis? To diagnose atopic dermatitis, also called eczema, a board-certified dermatologist carefully examines your (or your child's) skin and asks questions. ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial ...

Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of ...

The MarketWatch News Department was not involved in the creation of this content. EXTON, PA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- More than 31 million Americans are living with eczema/ atopic dermatitis ...